NCT07543978 Traditional Chinese Medicine for the Prevention of Radiotherapy-Induced Oral Mucositis (RTOM) Status NOT_YET_RECRUITING Phase PHASE3
NCT07400328 Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients Status RECRUITING Phase PHASE2
NCT07357597 An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer. Status NOT_YET_RECRUITING Phase PHASE4
NCT07322666 Non-Thermal Plasma vs. Low-Level Laser Therapy for Recurrent Oral Ulcers Status COMPLETED Phase NA
NCT06532279 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT06071637 Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT Status RECRUITING Phase PHASE3
NCT05878405 Methylene Blue Mouthwash for the Treatment of Oral Mucositis Pain in Patients With Cancer Status COMPLETED Phase PHASE3
NCT05323058 The Use of Tulsi Extract for The Management of Oral Mucositis in Head & Neck Cancer Patients Undergoing Radiotherapy Status UNKNOWN Phase PHASE2
NCT03778008 Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis Status UNKNOWN Phase PHASE2
NCT03581773 Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy Status RECRUITING Phase PHASE2
NCT03200340 EC-18 for Oral Mucositis in Patients With Concomitant Chemoirradiation Status COMPLETED Phase PHASE2
NCT02945878 Predictive Factors of Acute Oral Mucositis Induced by Chemo-radiotherapy for Local Advanced Nasopharyngeal Carcinoma Status UNKNOWN Phase N/A
NCT02735317 Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT Status UNKNOWN Phase PHASE2
NCT02531906 Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation Status COMPLETED Phase PHASE1
NCT02326675 Cryotherapy in the Prevention of Chemotherapy-Induced Mucositis in Stem Cell Transplant Status TERMINATED Phase NA